Randgold Resources: Vesting of Directors' Awards


JERSEY, CHANNEL ISLANDS--(Marketwired - Apr 20, 2015) - Randgold Resources (LSE: RRS) (NASDAQ: GOLD)

RANDGOLD RESOURCES LIMITED
 
Incorporated in Jersey, Channel Islands
 Reg. No. 62686
 LSE Trading Symbol: RRS
 NASDAQ Trading Symbol: GOLD
 (the "Company")

VESTING OF DIRECTORS' AWARDS UNDER THE RANDGOLD RESOURCES LIMITED CO-INVESTMENT PLAN AND THE RANDGOLD RESOURCES LIMITED RESTRICTED SHARE SCHEME

London, 20 April 2015

RANDGOLD RESOURCES LIMITED CO-INVESTMENT PLAN

The Company announces that on 20 April 2015, 28 843 ordinary shares in the Company ("Shares") were issued and allotted by the Company to Dr Mark Bristow, a director of the Company, and 6 462 Shares were issued and allotted by the Company to Graham Shuttleworth, a director of the Company, at their nominal value ($0.05) in satisfaction of the vesting of the awards granted on 16 March 2012 under the Randgold Resources Limited Co-Investment Plan (the "CIP Awards"). 

The CIP Awards are subject to a performance condition which measures the Company's Total Shareholder Return performance against the Euromoney Global Gold Index. This performance condition has been met at the maximum level in respect of each of the CIP Awards. Accordingly, the CIP Awards have vested in full.

Dr Mark Bristow's shareholding in the Company is now 757 772 Shares or 0.8% of the current issued share capital of the Company.

Graham Shuttleworth's shareholding in the Company is now 82 618 Shares or 0.09% of the current issued share capital of the Company.

The Randgold Resources Limited Co-investment Plan, which has been approved by shareholders, is designed to reward sustained total shareholder return performance relative to global peers over a three year period and align the interests of the executives with the interests of shareholders.

To view the full announcement, please click on the following link.

http://www.rns-pdf.londonstockexchange.com/rns/6872K_1-2015-4-20.pdf

Contact Information:

Contacts:
RNS
Customer Services
0044-207797-4400
rns@londonstockexchange.com
http://www.rns.com